Search

everythinglearnresearchcommunity

for

Search:↓

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Some drugs used to treat inflammation may cause hair loss.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The document is a detailed guide on skin conditions and treatments for dermatologists.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.